Signaling Pathway in the Osmotic Resistance Induced by Angiotensin II AT2 Receptor Activation in Human Erythrocytes

被引:5
|
作者
Guimaraes-Nobre, Camila Cristina [1 ,3 ]
Mendonca-Reis, Evelyn [1 ,3 ]
Passinho-da-Costa, Luana [1 ,5 ]
Miranda-Alves, Leandro [2 ,3 ,4 ]
Clemilson Berto-Junior, Hassan [1 ,2 ,3 ,5 ]
机构
[1] Univ Fed Rio de Janeiro, Grp Pesquisa Fisiol Eritroide GPFisEri, Campus Macae, Macae, Brazil
[2] Univ Fed Rio de Janeiro, Lab Endocrinol Expt LEEx, Inst Gencias Biomed, Rio De Janeiro, Brazil
[3] Univ Fed Rio de Janeiro, Fac Med, Programa Posgrad Endocrinol, Rio De Janeiro, Brazil
[4] Univ Fed Rio de Janeiro, Programa Posgrad Farmacol & Quim Med, Inst Ciencias Biomed, Rio De Janeiro, Brazil
[5] Univ Fed Rio Janeiro, Fac Farm, Campus Macae, Macae, Brazil
来源
关键词
Angiotensin II; Erythrocyte; Osmotic fragility; Signaling pathway; SYSTEM; CELLS; MAPK;
D O I
10.52547/rbmb.10.2.314
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Angiotensin II regulates blood volume via AT1 (AT1R) and AT2 (AT2R) receptors. As cell integrity is an important feature of mature erythrocyte, we sought to evaluate, in vitro, whether angiotensin II modulates resistance to hemolysis and the signaling pathway involved. Methods: Human blood samples were collected and hemolysis assay and angiotensin II signaling pathway profiling in erythrocytes were done. Results: Hemolysis assay created a hemolysis curve in presence of Ang II in several concentrations (10(-6) M, 10(-8) M, 10(-10) M, 10(-12) M). Angiotensin II demonstrated protective effect, both in osmotic stressed and physiological situations, by reducing hemolysis in NaCl 0.4% and 0.9%. By adding receptors antagonists (losartan, AT1R antagonist and PD 123319, AT2R antagonist) and/or signaling modulators for AMPK, Akt/PI3K, p38 and PKC we showed the protective effect was enhanced with losartan and abolished with PD 123319. Also, we showed activation of p38 as well as PI3K/Akt pathways in this system. Conclusions: Ang II protects human erythrocytes from hypo-osmotic conditions-induced hemolysis by activating AT2 receptors and triggering intracellular pathways.
引用
收藏
页码:314 / 326
页数:13
相关论文
共 50 条
  • [1] AT2 angiotensin II receptor activation of the nitric oxide/cGMP/PKG pathway modulates angiotensin II-induced activation of phospholipase D
    Andresen, BT
    Romero, GG
    Jackson, EK
    FASEB JOURNAL, 2002, 16 (05): : A951 - A952
  • [2] Possible role of Angiotensin II Receptor (AT2) in regulation of Insulin Receptor signaling
    Ramdas, Maya
    Kolhe, Ravindra
    Gavini, Nara
    Pulakat, Lakshmi
    FASEB JOURNAL, 2008, 22
  • [3] Possible role of Angiotensin II Receptor (AT2) in regulation of Insulin Receptor signaling
    Ramdas, Maya
    Kolhe, Ravindra
    Gavini, Nara
    Pulakat, Lakshmi
    FASEB JOURNAL, 2008, 22
  • [4] Two possible novel signaling mechanisms for the angiotensin II receptor AT2
    Pulakat, L
    Knowle, D
    Cooper, S
    Gavini, N
    BRAIN RESEARCH, 1999, 848 (1-2) : A27 - A27
  • [5] Angiotensin II, the AT2 receptor, and nuclear factor-κB activation
    Luft, FC
    KIDNEY INTERNATIONAL, 2002, 61 (06) : 2272 - 2273
  • [6] Diversity of angiotensin II signaling through the type-2 receptor, AT2
    Inagami, Tadashi
    Senbonmatsu, Takaaki
    Ding, R.
    Saito, T.
    Nakagawa, K.
    Satonaka, H.
    JOURNAL OF HYPERTENSION, 2006, 24 : 20 - 21
  • [7] Angiotensin AT2 receptor activates the cyclic-AMP signaling pathway in eel
    Wong, Marty Kwok-Shing
    Takei, Yoshio
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2013, 365 (02) : 292 - 302
  • [8] PREPARATION OF ANGIOTENSIN II AT2 RECEPTOR RIBOPROBES
    Correa, M. M.
    Arce, M. E.
    Ciuffo, G. M.
    Fuentes, L. B.
    BIOCELL, 2013, 37 (03) : A179 - A179
  • [9] Constitutive homodimerization of angiotensin II receptor AT2
    Cheng, Huaiyan
    Qiu, Rongde
    Wang, Mi
    Wang, Hu
    Feng, Ying-Hong
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 394 - 394
  • [10] Signaling mechanism of the AT2 angiotensin II receptor: Crosstalk between AT1 and AT2 receptors in cell growth
    Horiuchi, M
    Lehtonen, JYA
    Daviet, L
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1999, 10 (10): : 391 - 396